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denied previous head trauma of immunodefi ciency symp-
toms and family history was negative for similar disor-
ders.
Radiological analysis (Multislice Computed Tomogra-
phy of the paranasal sinuses and viscerocranium) was 
performed, and a formation of irregular contours, destroy-
ing the right zygomatic bone, was described, measuring 
25x17x20 mm in its widest diameters. Its medial border 
was adjacent to the lateral wall of the right maxillary si-
nus and the cortical bone in this segment was thinned, but 
preserved (Figure 1). Considering the MSCT (Multislice 
Computed Tomography) fi ndings, in an initial surgical 
procedure the right maxillary sinus was explored endo-
scopically, but the tumorous mass was not found. An ex-
ternal infraorbital probatory excision followed, based upon 
the radioglogist s MSCT fi ndings and descrption.
The histopathological fi nding showed, star-like tumor 
cells embedded in mucoid stroma and infi ltrating the bone 
(Figure 2). After pathohistological confi rmation of myxo-
ma, the tumor was excised in total, using infraorbital sur-
gical approach to the zygomatic bone (Figure 3a and b).
Myxoma is a benign tumor composed of primitive con-
nective tissue cells and mucousal stroma. Also referred to, 
as gelatinous or colloidal tumor.
Although rare, it can be found in the atrium of the 
heart and it is the most common heart tumor. It can de-
velop in a variety of locations, including subcutaneus and 
aponeurotic tissues, bones, genitourinary tract, skin, ret-
roperitoneum, intestine, pharynx, joints and sceletal 
muscles1.
Myxoma rarely occurs2 in the head and neck region, 
and in this region it is usually related to odontogenic 
myxoma of the maxilla and the mandibula, making 3–6% 
of all odontogenic tumors3.
Case Report
We report a case of a 57 years old female patient, with 
recurrent headaches located in the area of the right half 
of the face.
The patient had no remarkable medical history. Except 
for headeches, she did not report other symptoms. She 
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A B S T R A C T
Myxoma is a benign tumor composed of primitive connective tissue cells and mesenchymal mucousal stroma. Also 
referred to as, a gelationus or colloidal tumor. Although rare, it can be found in the atrium of the heart, and it is the most 
common heart tumor. It has also been described in other body sites, one of which is the bone. We report a case of a 57-year-
old female patient, with recurrent headaches located in the area of the right half of the face. Radiological analysis (Mul-
tislice Computed Tomography of the paranasal sinuses and viscerocranium) was performed, and a formation of irregular 
contours, destroying the right zygomatic bone, was described, measuring 25x17x20 mm in its widest diameters. Its me-
dial border was adjacent to the lateral wall of the right maxillary sinus and the cortical bone in this segment was thinned, 
but preserved. A probatory excision was performed in general anesthesia, and the histopathological fi nding showed, star-
like tumor cells embedded in mucoid stroma and infi ltrating the bone. After pathohistological confi rmation of myxoma, 
the tumor was excised in total, using infraorbital surgical approach to the zygomatic bone. During the follow-up, the 
patient was symptom free, without headaches, and there were no signs of local tumor recurrence. Despite of the fact that 
myxoma behaves as a benign disease in its nature, it can cause destruction of the tissue in the vicinity of the tumor itself, 
and thus major health issues for the patient. A timely proper diagnosis and the right choice of a surgical treatment can 
help avoid more extensive surgery procedures, as shown in our case report.
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During the follow-up, the patient was symptom free, 
without headaches, and there were no signs of local tumor 
recurrence.
At check up, a 18F-fl uorodeooxyglucose Positron Emis-
sion Tomography/Computed Tomography (18F-FDG PET/
CT) was performed and no abnormal fi ndings were found.
Discussion and Conclusion
Myxoma is the most common primary cardiac tumor 
and is classifi ed as benign in nature4. Suspicion for this 
diagnosis is raised in patients with cardiac syptoms or if 
throughout cardiac work-up, a tumor mass is found in car-
diac cavities, particularly in the left atrium.
The very fi rst case of myxoma was described by Virhow 
in 18715,6, but diagnostic criteria and myxoma defi nition 
was suggested by Stout in 18486,7.
This tumor incidence in the heart muscle is aproxi-
mately 0.5 per one million inhabitants per year8 and in-
tramuscular myxoma have an approximate incidence of 1 
per million of the population per year9. Incidence of myx-
oma tumor in bone structures is lower than mentioned 
above, and it is usually related to odontogenic tumors of 
the maxilla and the mandibula, making 3–6% of odonto-
genic tumors overall10. The etiology for myxoma has been 
unknown to this day. Familiar variants exist11, but most 
cases are sporadic, and more often found in middle aged 
female population12, as is was in our case, of a 57 years old 
female patient with unrelated familial history.
For some authors, chronic infl ammation has the lead-
ing role in the etiology of myxoma13, others relate it to 
immunosuppression, for example after organ transplanta-
tion13. A third group of authors describe hypoxia as a trig-
ger, creating appropriate microenvironment for tumor 
existance, addditionally activating vascular endothelial 
growth factor (VEGF) A, as an angiogenesis and vascular 
permeability promotor14.
Cases of myxoma related to chromosome 12 and 17 
abnormalities have been described in literature15. Often is 
the myxoma an accidental fi nding in symptom free pa-
tients.
In our patient’ s case, the main struggle was a pulsat-
ing headache in the right half of the face, in the projection 
of the right maxillary sinus.
It is important to accentuate the clinical signifi cance 
of bone lesions as showed in our case report.
In differential diagnosis, enteties that should be con-
sidered are: aggressive angiomyxoma, myxoid neurofi -
broma, myxoid liposarcoma, low-grade myxofi brosarcoma, 
cellular myxoma, juxta-articular myxoma and nodular 
fasciitis17. Usually, when myxoma becomes symptomatic 
in other locations than the heart, such as bone lesions, as 
it was the case with our patient, seldom is myxoma the 
fi rst diagnosis clinicians think of. After pathohistological 
confi rmation of myxoma, the tumor was excised in total, 
using infraorbital surgical approach to the zygomatic 
bone. Because of the existance of Mazabraud’s syndrome 
described in literatue, characterized by the association of 
single or multiple intramuscular myxomas with fi brous 
Fig. 1. Radiological analysis (Multislice Computed Tomogra-
phy of the paranasal sinuses and viscerocranium) showing a 
formation of irregular contours, destroying the right zygomatic 
bone, measuring 25x17x20 mm in its widest diameters.
Fig. 2. The histopathological fi nding: star-like tumor cells 
embedded in mucoid stroma (hemalaun-eosin staining, 40x).
Fig. 3. a) Infraorbital surgical approach to the zygomatic bone. 
b) Tumor tissue.
217
T. Braut: Myxoma of the Zygomatic Bone, Coll. Antropol. 39 (2015) 1: 215–217
dysplasia which can develop in a single bone or in multiple 
bones16, we performed 18F-fl uorodeooxyglucose Positron 
Emission Tomography /Computed Tomography (18F-FDG 
PET / CT). No bone lesions or fi brous dysplasia were found.
This myxoma case is also interesting for its unusual 
location. In the attainable literature, only three cases of 
zygomatic bone myxoma have been described so far.
Regardless of a non-metastatic tumor behavior, myxo-
ma is locally invasive in nature and characterised by slow, 
often, non-symptomatic growth, sometimes resulting in 
expansion and even perforation of the cortex of the in-
volved bone18.
Fortunately, due to exact diagnosis and prompt and 
effi cient surgical treatement, progression and bone de-
struction was succesfully prevented in our patient’s case.
The patient from this case report is currently asymp-
tomatic, showing no signs of tumor recurrence. She is com-
ing for regular check-ups, because of myxoma’s tendence 
to recidivation, often described in medical literature19.
In conclusion, despite the fact that myxoma behaves as 
a benign disease, it can cause destruction of surrounding 
tissues and structures, thus imparing the patient’s well 
being and life quality. Early diagnosis and surgical treat-
ment can help avoid more extensive surgical procedures, 
as shown in our case report.
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MIKSOM ZIGOMATIČNE KOSTI – PRIKAZ SLUČAJA
S A Ž E T A K
Miksom je dobroćudni tumor građen od primitivnih stanica vezivnog tkiva i mezenhimne sluzave strome. Naziva se 
još i gelatinoznim ili koloidnim tumorom. Iako rijedak, može se naći u srčanim pretklijetkama i najčešći je tumor srca. 
Opisan je i na drugim lokalizacijama, a jedna od njih je i kost. Prikazujemo slučaj 57-ogodišnje pacijentice koja se javlja 
zbog recidivirajuće glavobolje locirane u području desne polovice lica. Učinjenom radiološkom obradom (Višeslojna 
kompjuterizirana tomografi ja paranazalnih sinusa i viscerokranija) uoči se formacija nepravilnih kontura koja destru-
ira desnu zigomatičnu kost. U najširim promjerima opisana formacija je veličine 25x17x20 mm. Svojim medijalnim rubom 
naslanja se uz lateralnu stijenku desnog maksilarnog sinusa, kortikalna kost u tom segmentu je stanjena, ali održana. 
U općoj anesteziji učini se probatorna ekscizija te patohistološki nalaz pokaže zvjezdolike tumorske stanice koje infi l-
trativno rastu prema kosti uklopljene u mikoidnu stromu. Postavi se dijagnoza miksoma zigomatične kosti koji se u 
daljnjem postupku u potpunosti ekscidira infraorbitalnim pristupom na zigomatičnu kost. Tijekom perioda praćenja i 
kontrolnih pregleda,pacijentica je asimptomatična, bez znakova recidiva. Unatoč tome što se miksom predstavlja kao 
dobroćudna bolest, može biti uzrokom destrukcije tkivnih struktura u okolini tumora, a time i tegoba bolesnika. Pra-
vodobna dijagnoza te operacijsko liječenje mogu izbjeći opsežnije operativne zahvate, kao što je bilo u prikazanom slučaju.
